An unusual case of congenital primitive neuroectodermal tumor with ocular metastasis

J Pediatr Hematol Oncol. 2012 Mar;34(2):e69-71. doi: 10.1097/MPH.0b013e318221ca9b.

Abstract

Primitive neuroectodermal tumor (PNET) is most common in the second decade of life. Congenital PNET is very rare. Ocular metastasis of PNET is likewise exceedingly rare; with only 5 previously published cases. We report an unusual congenital PNET of the face, which metastasized to subcutis, eyes, and brain. The primary tumor responded to chemotherapy (vincristine/doxorubicin/cyclophosphamide) with metachronous progression of ocular lesions. A therapeutic trial of intraocular bevacizumab showed no efficacy on intraocular lesions. Eventually the patient developed cerebral metastasis, and second line therapy with topotecan/cyclophosphamide was initiated. The tumor progressed and the patient died after acute herniation.

Publication types

  • Case Reports

MeSH terms

  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use
  • Bevacizumab
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Eye Neoplasms / secondary*
  • Eye Neoplasms / therapy
  • Face / pathology
  • Fatal Outcome
  • Humans
  • Infant, Newborn
  • Male
  • Neuroectodermal Tumors, Primitive / congenital*
  • Neuroectodermal Tumors, Primitive / pathology*
  • Neuroectodermal Tumors, Primitive / therapy
  • Soft Tissue Neoplasms / congenital*
  • Soft Tissue Neoplasms / pathology*
  • Soft Tissue Neoplasms / therapy
  • Topotecan / administration & dosage
  • Vincristine / administration & dosage

Substances

  • Antibodies, Monoclonal, Humanized
  • Bevacizumab
  • Vincristine
  • Topotecan
  • Doxorubicin
  • Cyclophosphamide